General - Press Releases

Date	Title	Company
10-Jan-2022	Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical Trial Updates	Businesswire
10-Jan-2022	Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (γδ) T Cell Engager Therapies Targeting Solid Tumors	Businesswire
10-Jan-2022	Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies	Businesswire
10-Jan-2022	NovaBay Pharmaceuticals Expands Its Eyecare Product Portfolio With the Launch of Lubricating Eye Drops for the Immediate Relief of Dry Eye Symptoms	Businesswire
10-Jan-2022	Two Day Online Clinical Trial Regulatory Requirements Training Course (January 27-28, 2022) - ResearchAndMarkets.com	Businesswire
10-Jan-2022	Harrow Health to Participate in H.C. Wainwright BioConnect Conference	Businesswire
10-Jan-2022	Bristol Myers Squibb to Highlight Long-Term Growth Strategy at J.P. Morgan’s 40th Annual Healthcare Conference	Businesswire
10-Jan-2022	Merck’s KEYTRUDA® (pembrolizumab) Showed Statistically Significant Improvement in Disease-Free Survival Versus Placebo as Adjuvant Treatment for Patients With Stage IB-IIIA Non-Small Cell Lung Cancer Regardless of PD-L1 Expression	Businesswire
10-Jan-2022	Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics	Businesswire
10-Jan-2022	Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Diseases	Businesswire
10-Jan-2022	Humanigen Aligns with FDA on Potential Registration Phase 3 Study for Lenzilumab with CAR-T	Businesswire
10-Jan-2022	Global Dental Bone Grafts & Substitutes Market Research Report (2021 to 2026) - by Material Type, Application, End-user and Region - ResearchAndMarkets.com	Businesswire
10-Jan-2022	TISSIUM Appoints Ruth Krestin as Vice President of Portfolio Strategy	Businesswire
10-Jan-2022	Antibody Drug Conjugate Market Research Report 2022 by Mechanism of Action, Drugs, Technology, Application, End User - Global Forecast to 2027 - ResearchAndMarkets.com	Businesswire
10-Jan-2022	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
10-Jan-2022	Scailyte Closes Financing Round and Onboards Top Biotech Leaders to Prepare for Growth in 2022	Newswire
10-Jan-2022	Iksuda Therapeutics Deepens Clinical Pipeline Through Licensing Agreement for Her2 Antibody Drug Conjugate Programme From LegoChem Biosciences	Businesswire
10-Jan-2022	NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets	Businesswire
10-Jan-2022	Celyad Oncology Provides Outlook for 2022	Businesswire
10-Jan-2022	Pharmaron Acquires Commercial API Manufacturing Facility in the United Kingdom from Recipharm	Businesswire